Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
10 Nov, 2025
Deal Wrap is updated as of 3 p.m. ET.
– Dallas, Texas-based Cedar Springs Advisors LLC acquired Firearms Legal Protection LLC, a provider of legal and insurance services to firearm owners. Houlihan Lokey Inc. acted as financial adviser for Firearms Legal. Transaction details were not disclosed.
– Middle-market private equity firm Lindsay Goldberg LLC agreed to acquire EMCO Chemical Distributors Inc., a founder-owned distributor of industrial chemicals based in Pleasant Prairie, Wisconsin. Financial terms of the transaction were not disclosed. Latham & Watkins was legal adviser, while Chemlink Partners and JPMorgan acted as financial advisers to Lindsay Goldberg. Aronberg Goldgehn provided legal advice to EMCO.
– Andreessen Horowitz LLC led a $68 million Series B funding round for Gamma Tech Inc., an AI platform for visual storytelling, valuing the company at $2.1 billion. Gamma aims to replace PowerPoint with its AI-powered platform. The round includes a secondary raise to provide liquidity for early employees.
– China-based Cornerstone Robotics, a developer of surgical robots for the healthcare industry, received $200 million in a round of funding led by new investor Hong Kong Investments Group Ltd. The transaction includes participation from returning investors BridgeOne Capital, Gaorong Capital and others. The company has issued convertible preferred shares. Cornerstone will use the proceeds for commercialization efforts in China and overseas, to fund clinical trials, and to advance product R&D.
Disclaimer: This content may be AI-assisted and is composed, reviewed, edited and approved by a human at S&P Global.
For more private equity deals, read our latest In Play report, which looks at potential private equity-backed M&A, including rumored transactions, each week.